{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:46:33Z","timestamp":1764510393353},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00277-011-1169-4","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T11:14:13Z","timestamp":1297077253000},"page":"1241-1243","source":"Crossref","is-referenced-by-count":9,"title":["CML with e6a2 BCR-ABL1 transcript: an aggressive entity?"],"prefix":"10.1007","volume":"90","author":[{"given":"Karolien Anne","family":"Beel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Vranckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"issue":"4","key":"1169_CR1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.leu.2404949","volume":"22","author":"S Schnittger","year":"2008","unstructured":"Schnittger S, Bacher U, Kern W, Haferlach T, Hertenstein B, Haferlach C (2008) A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment. Leukemia 22(4):856\u2013858","journal-title":"Leukemia"},{"issue":"5","key":"1169_CR2","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/10428190701216402","volume":"48","author":"F Torres","year":"2007","unstructured":"Torres F, Ivanova-Dragoeva A, Pereira M, Veiga J, Rodrigues AS, Sousa AB, Tavares P, Fernandes AR (2007) An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation. Leuk Lymphoma 48(5):1034\u20131037","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1169_CR3","first-page":"611","volume":"89","author":"S Colla","year":"2004","unstructured":"Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P, Giuliani N (2004) e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease? Haematologica 89(5):611\u2013613","journal-title":"Haematologica"},{"issue":"6","key":"1169_CR4","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V88.6.2236.bloodjournal8862236","volume":"88","author":"A Hochhaus","year":"1996","unstructured":"Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC (1996) A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood 88(6):2236\u20132240","journal-title":"Blood"},{"issue":"11","key":"1169_CR5","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/sj.leu.2401916","volume":"14","author":"M Dupont","year":"2000","unstructured":"Dupont M, Jourdan E, Chiesa J (2000) Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML. Leukemia 14(11):2011\u20132012","journal-title":"Leukemia"},{"issue":"10","key":"1169_CR6","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/sj.leu.2403079","volume":"17","author":"B Schultheis","year":"2003","unstructured":"Schultheis B, Wang L, Clark RE, Melo JV (2003) BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Leukemia 17(10):2054\u20132055","journal-title":"Leukemia"},{"issue":"8","key":"1169_CR7","first-page":"1139","volume":"90","author":"G Roti","year":"2005","unstructured":"Roti G, La Starza R, Gorello P, Gottardi E, Crescenzi B, Martelli MF, Mecucci C (2005) e6a2 BCR\/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia. Haematologica 90(8):1139\u20131141","journal-title":"Haematologica"},{"issue":"9","key":"1169_CR8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/10428190500138138","volume":"46","author":"C Popovici","year":"2005","unstructured":"Popovici C, Cailleres S, David M, Lafage-Pochitaloff M, Sainty D, Mozziconacci MJ (2005) E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib. Leuk Lymphoma 46(9):1375\u20131377","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1169_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.leukres.2007.05.022","volume":"32","author":"M Breccia","year":"2008","unstructured":"Breccia M, Cannella L, Diverio D, Streponi P, Nanni M, Stefanizzi C, Natalino F, Mecarocci S, Alimena G (2008) Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR\/ABL fusion transcript, JAK2 negativity and complete response to imatinib. Leuk Res 32(1):177\u2013180","journal-title":"Leuk Res"},{"issue":"1","key":"1169_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000230037","volume":"122","author":"HK Vefring","year":"2009","unstructured":"Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009) Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases. Acta Haematol 122(1):11\u201316","journal-title":"Acta Haematol"},{"issue":"8","key":"1169_CR11","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.leukres.2010.02.022","volume":"34","author":"SE Langabeer","year":"2010","unstructured":"Langabeer SE, Crampe M, Kelly J, Fadalla K, Connaghan G, Conneally E (2010) Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts. Leuk Res 34(8):e204\u2013e205","journal-title":"Leuk Res"},{"issue":"12","key":"1169_CR12","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ Dongen van","year":"1999","unstructured":"van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, Parreira A, Gameiro P, Diaz MG, Malec M, Langerak AW, San Miguel JF, Biondi A (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13(12):1901\u20131928","journal-title":"Leukemia"},{"issue":"21\u201322","key":"1169_CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00508-008-1100-8","volume":"120","author":"P Valent","year":"2008","unstructured":"Valent P, Lion T, Wolf D, Sillaber C, Agis H, Petzer A, Lang A, Kahls P, Geissler D, Greil R, Linkesch W, Burgstaller S, Thaler J, Gastl G (2008) Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform. Wien Klin Wochenschr 120(21\u201322):697\u2013709","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"1169_CR14","first-page":"186","volume":"8","author":"NC Cross","year":"1994","unstructured":"Cross NC, Melo JV, Feng L, Goldman JM (1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 8(1):186\u2013189","journal-title":"Leukemia"},{"issue":"4","key":"1169_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2353\/jmoldx.2009.090008","volume":"11","author":"N Jinawath","year":"2009","unstructured":"Jinawath N, Norris-Kirby A, Smith BD, Gocke CD, Batista DA, Griffin CA, Murphy KM (2009) A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia. Diagnostic challenges in clinical laboratory practice. J Mol Diagn 11(4):359\u2013363","journal-title":"J Mol Diagn"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1169-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T10:10:19Z","timestamp":1592302219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1169-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,8]]}}}